A Double Blind (3rd Party Open), Randomized, Placebo Controlled, Dose Escalation Study To Investigate The Safety, Toleration, And Pharmacokinetics Of Multiple Inhaled Doses Of PF-03715455 In Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 17 Jan 2011
At a glance
- Drugs PF 3715455 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- 17 Jan 2011 Planned end date changed from 1 Nov 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.
- 11 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Sep 2010 New trial record